Nanotechnology Now - News Story: "Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?"

Home > News > Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?

September 13th, 2005

Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?

Abstract:
Nanotechnology is poised to enable advances that could be utilized to shave time and expense from multiple stages of the drug discovery and development efforts.

Source:
nano.cancer.gov

Bookmark:

Related Links

Ohio State University

National Cancer Institute

Related News Press

Possible Futures

The "Tipping Point" February 12th, 2014

UCF Researcher Bringing 3-D TV Back From The Dead February 12th, 2014

Diamond Defect Boosts Quantum Technology February 4th, 2014

Iran to Hold 2nd Prototype Nanotechnology Products Competition January 21st, 2014

Nanomedicine

MANA Research Highlight: Smart nanofibers to treat kidney failure March 6th, 2014

Harris & Harris Group, Inc. Establishes and Invests $350,001 in ProMuc, Inc. March 6th, 2014

First Look at How Individual Staphylococcus Cells Adhere to Nanostructures Could Lead to New Ways to Thwart Infections: Berkeley Lab-led research could guide the development of bacteria-resistant materials March 5th, 2014

Dartmouth Researchers Find Promising Results with Local Hyperthermia of Tumors March 4th, 2014